By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Swedish Orphan Biovitrum 


  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a



Company News
Invitation - Presentation Of Swedish Orphan Biovitrum's Q2 2017 Results 7/6/2017 8:16:36 AM
Bioverativ (BIVV) And Swedish Orphan Biovitrum Highlight Commitment To Improving Care For People With Hemophilia At ISTH 2017 Congress 7/6/2017 6:39:17 AM
Swedish Orphan Biovitrum Release: FDA Grants SOBI003 Orphan Drug Designation For The Treatment Of MPS IIIA 7/5/2017 7:09:30 AM
Swedish Orphan Biovitrum Release: Xiapex Gets Recommendation To Be Made Available On National Health Service In England 6/30/2017 8:48:29 AM
Swedish Orphan Biovitrum Release: EMA Approves The Potential To Dose Every 14 Days Or Longer In Updated Dosing Regimen For Alprolix 6/27/2017 7:06:25 AM
Swedish Orphan Biovitrum - Orfadin Capsules Approved In The Kingdom Of Saudi Arabia For The Treatment Of Hereditary Tyrosinemia Type 1 5/17/2017 6:32:06 AM
Swedish Orphan Biovitrum Release: First Patients Enrolled In 24 Month Real-World Study Evaluating Effectiveness Of Elocta 1/19/2017 7:55:30 AM
Swedish Orphan Biovitrum: Elocta Approved in Kuwait For The Treatment Of Hemophilia A 11/21/2016 12:39:17 PM
Swedish Orphan Biovitrum: European Study Of Real-Life Hemophilia Treatment Emphasizes Need To Improve Standard Of Care 11/14/2016 12:07:06 PM
Swedish Orphan Biovitrum: Alprolix Approved In Switzerland For The Treatment Of Hemophilia B 10/28/2016 9:52:03 AM